Researchers at Mount Sinai School of Medicine have found that patients with Alzheimer's disease have lower glucose utilization in the brain than those with normal cognitive function, and that those decreased levels may be detectable approximately 20 years prior to the first symptoms of Alzheimer's disease. This new finding could lead to the development of novel therapies to prevent the eventual onset of Alzheimer's. The study is published online in the journal Translational Neuroscience.
As a kid growing up near the space program in Huntsville, Ala., reading as much science fiction as he could get his hands on, Kasting had space exploration on his mind all the time. It influenced who he is today as well as the research he's most interested in conducting. By studying early Earth's atmosphere and the origins of oxygen in it, Kasting has become one of the foremost experts on planetary habitable zones. In his book, "How to Find a Habitable Planet," Kasting explains how his research with NASA may be able to detect worlds outside of our solar system that are suitable for sustaining life.
Sarah Saurer was seven years old when she was diagnosed with brain cancer.
Her parents soon found out that several other children in their small town -- which sat just miles away from two troubled Illinois nuclear power plants -- had been diagnosed with brain cancer and leukemia.
Then news broke that one of the plants had been leaking radioactive water for years before it was detected. A quick survey by concerned mothers found that every single home within a quarter mile of the spill housed someone who'd been diagnosed with cancer.
"I want to remind you how important it is to protect people from the harmful things that are being put into our environment," Sarah Saurer told the scientists, her short stature and child-like face showing little sign of her 17 years.
A class of engineered nanoparticles -- gold-centered spheres smaller than viruses -- has been shown safe when administered by two alternative routes in a mouse study led by investigators at the Stanford University School of Medicine. This marks the first step up the ladder of toxicology studies that, within a year and a half, could yield to human trials of the tiny agents for detection of colorectal and possibly other cancers.
Zooniverse volunteers, who call themselves "Zooites," are working on a project called Galaxy Zoo, classifying distant galaxies imaged by NASA's Hubble Space Telescope.
"Not only are people better than computers at detecting the subtleties that differentiate galaxies, they can do things computers can't do, like spot things that just look interesting," explains Zooniverse director Chris Lintott, an astronomer at the University of Oxford.